Infectious Disease

Siemens Healthineers offers a broad portfolio of infectious disease (ID) testing capabilities across diagnostic disciplines, from screening and diagnosis to genotyping, therapy and monitoring.

Accurate identification of immune response to support long term COVID-19 management

SARS-CoV-2 IgG Assay*

The first FDA EUA-authorized semi-quantitative assay to help clinicians assess the level of an individual‘s immune response
SARS-CoV-2 Total Assay from Siemens Healthineers

SARS-CoV-2 Total Assay*

Secure your community with science and scale
Jim Freeman

Educational Video: Behind the design of the Siemens Healthineers SARS-CoV-2 Total Assay

Hear from Jim Freeman, the Vice President of Research and Development, Global Immunoassay Development at Siemens Healthineers
Infographic: Build programs to more safely and efficiently reopen communities, businesses and schools

Infographic: Testing is key to reopening

There are numerous tests to help detect SARS-CoV-2 virus or antibodies to the virus. Only a few are highly accurate.
Specificity Matters

Why Specificity Matters in COVID-19 antibody testing

Learn why specificity matters for antibody testing during the COVID-19 pandemic
Role of Antibody Tests in COVID-19

Role of Antibody Tests in COVID-19

Highly accurate antibody tests help inform clinical and public health decisions as we look towards safely opening our communities.
FTD SARS-CoV-2 Assay (RUO)

FTD SARS-CoV-2 Assay

For the identification of the coronavirus causing COVID-19.
Hepatitis Test Solutions

Hepatitis Test Solutions

Offer your clinicians high-performance hepatitis test results run on our proven automated platforms
TORCH and Special ID Assay menu

TORCH and Special ID Assays

Make automated infectious-disease screening part of your routine testing
Healthy Mother/Healthy Baby Thought Leadership Webinar Series

Webinar: Optimal Pregnancy Outcomes through Proper ID Testing

Explore our AACC Healthy Mother/Healthy Baby Thought Leadership Webinar Series
ADVIA Centaur Zika Test

ADVIA Centaur Zika Test

An automated Zika test to detect IgM antibodies to the Zika Virus
Antibody testing satisfies FDA requirement for SARS-CoV-2 vaccine development

Siemens Healthineers antibody assays meet and exceed FDA EUA guidance for assessment of immune response

Learn how antibody testing satisfies FDA requirement for SARS-CoV-2 vaccine development

Share this page:

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

*This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary by country and is subject to regulatory requirements.

1For research use only (RUO). Pursuing FDA emergency use authorization (EUA). Pursuing WHO emergency use assessment and listing (EUAL) certification.